Display search results for ** instead (21 products)

Showing 1-10 of 21

16 Feb 2021  |  North America

Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Market

Mobility Ecosystem Holds Bold Promise to Expand Patients’ Access to Care

Smartphone-based devices and associated tools are becoming the ideal next-generation point-of-care testing (POCT) solutions for in vitro diagnostics. The global COVID-19 pandemic has led to frugal innovations in POCT. The World Health Organization (WHO) has endorsed POCT as the topmost research priority in response to the COVID-19 outbreak. Digital...

USD 2,450.00
19 Feb 2021  |  North America

Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market

High Unmet Needs in Niche Oncology Indications will Drive Future Growth Potential

Frost & Sullivans Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and c...

USD 2,450.00
09 Mar 2021  |  South Asia, Middle East & North Africa

Innovative Public-Private Partnerships Transforming the KSA Healthcare Industry, Outlook 2021

Future Growth Potential Enhanced by Healthcare Infrastructure Upgrade Strategies and Digitization Initiatives

The Kingdom of Saudi Arabia (KSA) is expected to experience economic growth despite oil price complications due to its economic diversion from the oil industry to other industries, with initiatives and strategies that encourage private sector participation. Apart from robust economic growth, the regions business environment will also change radical...

USD 2,450.00
26 Mar 2021  |  Global

Payment Reforms and Digital Technologies to Drive Future of Hospital at Home Care Models

Increasing number of diverse acute conditions to be covered under Hospital at Home Care Model

Hospital at Home is an innovative care model for healthcare organizations to provide hospital-level care in home for patients who meet acute inpatient admission requirements. CMS states that under this model, the patient home is considered part of the hospital during the tenure of care. The study provides a detailed understanding of the hospital at...

USD 2,450.00
29 Mar 2021  |  Global

Data Monetization Drives Innovative Business Models in the Global MedTech Industry

Data-Enabled Growth Strategies Counterbalance Competitive Intensity

With the advent of digitization in healthcare, all industry efforts are geared toward better leveraging this stream of digital data to achieve the goals of precision medicine and precision health. The amount of health data that is becoming available is increasing exponentially each year, with new sources, such as wearable devices and social determi...

USD 2,450.00
30 Apr 2021  |  North America

US COVID-19 Vaccines and Therapeutics Tracker—Market Insights and Trends, H1 2021

Agnostic Vaccine Platform Technology Enhancing Future Growth Potential of Participants in the Value Chain

This study by Frost & Sullivans Healthcare and Life Sciences team provides critical insights into the US COVID-19 vaccines and therapeutics market, including developing vaccines, supply chain considerations, and requirements to manage distribution. The study also identifies actionable and profitable growth opportunities for industry participants. T...

USD 2,450.00
21 May 2021  |  North America

Explosion of Data Drives the US Social Determinants of Health Market

Proven Returns on Investment will Ignite Transformational Growth

This report from Frost & Sullivan Healthcare and Life Sciences focuses on the potential to cater to healthcare needs based on data-driven social determinants of health (SDOH). Although the traditional practice of healthcare involves the use of medical technology and protocols to maintain and restore health, the SDOH concept adds another dimension. ...

USD 2,450.00
30 Jun 2021  |  North America

US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities

Telegenetic Counseling to Revolutionize Access to Patient Care

In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...

USD 2,450.00
06 Jul 2021  |  North America

Global Decentralized Clinical Trial (DCT) Growth Opportunities

Strategic Partnering and M&A Activity in At-home Monitoring Solutions Gain Momentum

Frost & Sullivan presents post–COVID-19 growth opportunities and strategic imperatives for the global decentralized clinical trials (DCT) market, covering the markets maturity, key participants, adoption drivers and restraints, and recent mergers and acquisitions. The report identifies initiatives by major global contract research organizations (...

USD 2,450.00
07 Jul 2021  |  North America

United States Healthcare Consumerism Growth Opportunities

The Quantified Self Consumer Behavior and Innovative Business Models Create Future Growth Potential

This research service examines the future of healthcare consumerism in the United States in terms of changing patient demographics and demands, technological advancements, digital health, shift in consumer behavior to non-traditional healthcare settings, and innovative healthcare business models. Healthcare consumerism is on the rise as individual...

USD 2,450.00

Showing 1-10 of 21